GNAS and pancreatic intraductal papillary-mucinous neoplasm: Despite the insufficiently accurate for predicting the histological grades of IPMN, GNAS mutation detection in plasma cfDNA from patients with PCNs can be an evolving tool distinguishing IPMN from other types of PCNs such as MCN, SCN, and SPN.